Form 8-K - Current report:
SEC Accession No. 0001213900-26-044125
Filing Date
2026-04-15
Accepted
2026-04-15 17:00:17
Documents
11
Period of Report
2026-04-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0286510-8k_mainz.htm   iXBRL 8-K 24357
  Complete submission text file 0001213900-26-044125.txt   189928

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE mynz-20260409.xsd EX-101.SCH 3023
3 XBRL LABEL FILE mynz-20260409_lab.xml EX-101.LAB 34239
4 XBRL PRESENTATION FILE mynz-20260409_pre.xml EX-101.PRE 22364
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0286510-8k_mainz_htm.xml XML 3206
Mailing Address ROBERT KOCH STRASSE 50 MAINZ 2M 55129
Business Address ROBERT KOCH STRASSE 50 MAINZ 2M 55129 49 6131 5542860
MAINZ BIOMED N.V. (Filer) CIK: 0001874252 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41010 | Film No.: 26864781
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)